|
1
|
Zainuddin N, Jaafart H, Isa MN, et al:
Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in
malays with malignant glioma. Neurol Res. 26:88–92. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nishisaka T, Takeshima Y and Inai K:
Evaluation of p53 gene mutation and loss of heterozygosity of 3p,
9p and 17p in precancerous lesions of 29 lung cancer patients.
Hiroshima J Med Sci. 49:109–116. 2000.PubMed/NCBI
|
|
3
|
Wistuba II, Behrens C, Milchgrub S, et al:
Sequential molecular abnormalities are involved in the multistage
development of squamous cell lung carcinoma. Oncogene. 18:643–650.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Perinchery G, Bukurov N, Nakajima K, et
al: High frequency of deletion on chromosome 9p21 may harbor
several tumor-suppressor genes in human prostate cancer. Int J
Cancer. 83:610–614. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Partridge M, Emilion G, Pateromichelakis
S, et al: Location of candidate tumour suppressor gene loci at
chromosomes 3p, 8p and 9p for oral squamous cell carcinomas. Int J
Cancer. 83:318–325. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calin GA, Dumitru CD, Shimizu M, et al:
Frequent deletions and down-regulation of micro-RNA genes miR15 and
miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci
USA. 99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Peng S, Fan S, Li X, et al: The expression
of ezrin in NPC and its interaction with NGX6, a novel candidate
suppressor. Cancer Sci. 8:341–349. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma J, Zhou J, Fan S, et al: Role of a
novel EGF-like domain-containing gene NGX6 in cell adhesion
modulation in nasopharyngeal carcinoma cells. Carcinogenesis.
26:281–291. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang L, Ma J, Li J, et al: NGX6 gene
inhibits cell proliferation and plays a negative role in EGFR
pathway in nasopharyngeal carcinoma cells. J Cell Biochem.
95:64–73. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 6:69–90. 2011. View Article : Google Scholar
|
|
11
|
Xiong J, Yu D, Wei N, et al: An estrogen
receptor alpha suppressor, microRNA-22, is downregulated in
estrogen receptor alpha-positive human breast cancer cell lines and
clinical samples. FEBS J. 277:1684–1694. 2010. View Article : Google Scholar
|
|
12
|
Hu Y, Fan L, Zheng J, et al: Detection of
circulating tumor cells in breast cancer patients utilizing
multiparameter flow cytometry and assessment of the prognosis of
patients in different CTCs levels. Cytometry A. 77:213–219. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou FF, Xia LP, Wang X, et al: Analysis
of prognostic factors in male breast cancer: a report of 72 cases
from a single institution. Chin J Cancer. 29:184–188. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Arpino G, De Angelis C, Giuliano M, et al:
Molecular mechanism and clinical implications of endocrine therapy
resistance in breast cancer. Oncology. 77(Suppl 1): 23–37. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Henry NL and Hayes DF: Can biology trump
anatomy? Do all node-positive patients with breast cancer need
chemotherapy? J Clin Oncol. 25:2501–2503. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jaiyesimi IA, Buzdar AU, Decker DA, et al:
Use of tamoxifen for breast cancer: twenty-eight years later. J
Clin Oncol. 13:513–529. 1995.PubMed/NCBI
|
|
17
|
Kim MR, Choi HK, Cho KB, et al:
Involvement of Pin1 induction in epithelial-mesenchymal transition
of tamoxifen-resistant breast cancer cells. Cancer Sci.
100:1834–1841. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
|
|
19
|
Markaryan A, Nelson EG, Tretiakova M, et
al: Technical report: immunofluorescence and TUNEL staining of
celloidin embedded human temporal bone tissues. Hear Res. 241:1–6.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hurst PR, Mora JM and Fenwick MA:
Caspase-3, TUNEL and ultrastructural studies of small follicles in
adult human ovarian biopsies. Hum Reprod. 21:1974–1980. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bennett-Lovsey RM, Herbert AD, Sternberg
MJ, et al: Exploring the extremes of sequence/structure space with
ensemble fold recognition in the program Phyre. Proteins.
70:611–625. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kelley LA and Sternberg MJ: Protein
structure prediction on the Web: a case study using the Phyre
server. Nat Protoc. 4:363–371. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Martí-Renom MA, Stuart AC, Fiser A, et al:
Comparative protein structure modeling of genes and genomes. Annu
Rev Biophys Biomol Struct. 29:291–325. 2000.
|
|
24
|
Szklarczyk D, Franceschini A, Kuhn M, et
al: The STRING database in 2011: functional interaction networks of
proteins, globally integrated and scored. Nucleic Acids Res.
39(Database issue): D561–D568. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
D’Arcangelo G, Miao GG, Chen SC, et al: A
protein related to extracellular matrix proteins deleted in the
mouse mutant reeler. Nature. 374:719–723. 1995.
|
|
26
|
Wang L, Xiang B, Yi M, et al:
Identification of a new seven-span transmembrane protein: NGX6a is
downregulated in nasopharyngeal carcinoma and is associated with
tumor metastasis. J Histochem Cytochem. 58:41–51. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo Q, Shen S, Liao M, et al: NGX6
inhibits cell invasion and adhesion through suppression of
Wnt/betacatenin signal pathway in colon cancer. Acta Biochim
Biophys Sin. 42:450–456. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xiao JD and Shen SR: Expression and
significance of NGX6 gene in human hepatocellular carcinoma. Zhong
Nan Da Xue Xue Bao Yi Xue Ban. 33:937–941. 2008.PubMed/NCBI
|
|
29
|
Eskandari-Nasab E, Hashemi M, Rezaei H, et
al: Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and
dihydrofolate reductase (DHFR) genes deletion and the expression
level of NGX6 mRNA in breast cancer. Mol Biol Rep. 39:10531–10539.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang XY, Wu MH, Liu F, et al: Differential
miRNA expression and their target genes between NGX6-positive and
negative colon cancer cells. Mol Cell Biochem. 345:283–290. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guo Q, Wu M, Lian P, et al: Synergistic
effect of indomethacin and NGX6 on proliferation and invasion by
human colorectal cancer cells through modulation of the
Wnt/beta-catenin signaling pathway. Mol Cell Biochem. 330:71–81.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Peng Y, Li H, Wu M, et al: NGX6 inhibits
AP-1 and Ets-1 expression and down-regulates cyclin D1 in human
colorectal cancer. Acta Biochim Biophys Sin. 41:504–514. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schmierer B and Hill CS: TGFbeta-SMAD
signal transduction: molecular specificity and functional
flexibility. Nat Rev Mol Cell Biol. 8:970–982. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jacob D, Davis J, Zhu H, et al:
Suppressing orthotopic pancreatic tumor growth with a
fiber-modified adenovector expressing the TRAIL gene from the human
telomerase reverse transcriptase promoter. Clin Cancer Res.
10:3535–3541. 2004. View Article : Google Scholar
|
